journal article·2026-07Open access

Sex‐Specific Regulation of Glycemic Homeostasis by Theabrownin from Pu‐erh Tea

Yang Li, Junliang Kuang, Dan Zheng, Jieyi Wang, Kun Ge, Chun Qu, Xiaojiao Zheng, Zhenxing Ren, Fengjie Huang, Mingliang Zhao, Yimin Sun, Huiheng Zhang, Keke Ding, Xixi Xia, Yajun Tang, Lu Liu, Jian Zhou, Fei Gao, Xiaohui Ma, Yongquan Xu, Guoxiang Xie, Aihua Zhao, Wei Jia

Advanced Science· Volume 13· Issue 38

Abstract

ABSTRACT Theabrownin (TB) from Pu‐erh tea has demonstrated efficacy in alleviating hyperglycemia, yet its mechanism remains incompletely understood. In our study, we found that Pu‐erh tea or TB intervention effectively lowered postprandial blood glucose levels in females with normal and impaired glucose tolerance (IGT), as well as in hyperglycemic mouse models. Specifically, oral administration of Pu‐erh tea or TB led to the inhibition of small intestinal α‐glucosidase activity in a female‐specific manner. TB's inhibition of α‐glucosidase in vivo was significantly enhanced by mucin 2 (MUC2), a protein enriched in female intestinal mucin and upregulated by estradiol. Through noncovalent interactions, TB binds to MUC2 to form a complex, significantly boosting its inhibitory effect on α‐glucosidase in females. These findings reveal the sex‐specific molecular mechanism underlying the blood glucose‐lowering effects of TB from Pu‐erh tea, offering a promising intervention for maintaining glycemic balance in individuals with IGT or type 2 diabetes. Additionally, our study highlights the importance of considering sex differences in the judicious use of supplements or pharmacotherapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Tea Polyphenols and Effects · Phytochemicals and Antioxidant Activities · Natural Antidiabetic Agents Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center For Translational Medicine Shanghai Key Laboratory of Diabetes Mellitus Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai China

Human Metabolomics Institute, Inc. Shenzhen China

Department of Pharmacology and Pharmacy University of Hong Kong Hong Kong China

Department of Endocrinology and Metabolism Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai China

Tasly Research Institute Tianjin China

School of Pharmacy, Health Science Center Ningbo University Ningbo China

Funding

National Natural Science Foundation of China · National Key Research and Development Program of China

References (76)

Show source-provided references
1. 10.1016/S0140‐6736(22)01655‐510.1016/S0140‐6736(22)01655‐5 ↗
2. 10.1007/s00125‐023‐05891‐x10.1007/s00125‐023‐05891‐x ↗
3. 10.1016/S2213‐8587(17)30336‐410.1016/S2213‐8587(17)30336‐4 ↗
4. 10.1007/s00125‐020‐05169‐610.1007/s00125‐020‐05169‐6 ↗
5. 10.1155/2018/540612810.1155/2018/5406128 ↗
6. 10.2337/diabetes.52.2.24410.2337/diabetes.52.2.244 ↗
7. 10.1530/EJE‐18‐060210.1530/EJE‐18‐0602 ↗
8. 10.2337/dc12‐173810.2337/dc12‐1738 ↗
9. 10.1210/jc.2010‐139810.1210/jc.2010‐1398 ↗
10. 10.1007/s00125‐010‐1673‐410.1007/s00125‐010‐1673‐4 ↗
11. 10.1001/jama.2016.1972010.1001/jama.2016.19720 ↗
12. 10.1016/j.jns.2018.03.00810.1016/j.jns.2018.03.008 ↗
13. 10.1007/s12020‐016‐1014‐610.1007/s12020‐016‐1014‐6 ↗
14. 10.1136/bmjdrc‐2020‐00143010.1136/bmjdrc‐2020‐001430 ↗
15. 10.1016/j.jtcms.2022.04.00510.1016/j.jtcms.2022.04.005 ↗
16. 10.1016/j.foodchem.2019.12604310.1016/j.foodchem.2019.126043 ↗
17. 10.1038/s41467‐019‐12896‐x10.1038/s41467‐019‐12896‐x ↗
18. 10.3390/metabo1011047510.3390/metabo10110475 ↗
19. 10.1039/d1fo03374c10.1039/d1fo03374c ↗
20. 10.1039/c9fo01334b10.1039/c9fo01334b ↗
21. 10.1039/c4fo01025f10.1039/c4fo01025f ↗
22. 10.1002/14651858.CD005061.pub210.1002/14651858.CD005061.pub2 ↗
23. 10.2165/00003495‐200666030‐0000110.2165/00003495‐200666030‐00001 ↗
24. 10.1016/s0195‐668x(03)00468‐810.1016/s0195‐668x(03)00468‐8 ↗
25. Expert Consensus on the Clinical Application of α‐glucosidase Inhibitors in China
26. 10.2165/00003495‐199957010‐0000310.2165/00003495‐199957010‐00003 ↗
27. 10.1210/jc.2009‐150310.1210/jc.2009‐1503 ↗
28. 10.1097/MPG.000000000000198010.1097/MPG.0000000000001980 ↗
29. 10.1002/mnfr.20090046710.1002/mnfr.200900467 ↗
30. 10.1016/j.bbrc.2007.04.07010.1016/j.bbrc.2007.04.070 ↗
31. 10.1136/gutjnl‐2020‐32226010.1136/gutjnl‐2020‐322260 ↗
32. 10.1146/annurev‐biochem‐011520‐10505310.1146/annurev‐biochem‐011520‐105053 ↗
33. 10.2337/db22‐019210.2337/db22‐0192 ↗
34. 10.1021/jf505469k10.1021/jf505469k ↗
35. 10.1021/acs.jafc.1c0462610.1021/acs.jafc.1c04626 ↗
36. 10.1007/s00535‐015‐1154‐010.1007/s00535‐015‐1154‐0 ↗
37. 10.1007/s00018‐016‐2247‐510.1007/s00018‐016‐2247‐5 ↗
38. 10.1007/s00125‐004‐1409‐410.1007/s00125‐004‐1409‐4 ↗
39. 10.2174/13895571280126483710.2174/138955712801264837 ↗
40. 10.1080/10408398.2023.223670110.1080/10408398.2023.2236701 ↗
41. 10.1016/j.ijbiomac.2023.12386210.1016/j.ijbiomac.2023.123862 ↗
42. 10.3389/fcimb.2022.85696210.3389/fcimb.2022.856962 ↗
43. 10.3390/foods1101009810.3390/foods11010098 ↗
44. 10.1007/s00018‐024‐05124‐310.1007/s00018‐024‐05124‐3 ↗
45. 10.1016/j.chom.2011.12.00610.1016/j.chom.2011.12.006 ↗
46. 10.1016/j.jnutbio.2022.10920610.1016/j.jnutbio.2022.109206 ↗
47. 10.1007/s00535‐016‐1305‐y10.1007/s00535‐016‐1305‐y ↗
48. 10.5009/gnl1822110.5009/gnl18221 ↗
49. 10.1016/S0140‐6736(99)01436‐110.1016/S0140‐6736(99)01436‐1 ↗
50. 10.1097/01.gme.0000233170.42174.3710.1097/01.gme.0000233170.42174.37 ↗
51. 10.1093/humupd/dmad01610.1093/humupd/dmad016 ↗
52. 10.1016/j.addr.2021.05.01410.1016/j.addr.2021.05.014 ↗
53. 10.1155/2011/18710310.1155/2011/187103 ↗
54. Sex Differences in Drug Action: the Role of Multidrug‐resistance Proteins (MRPs)
55. 10.1021/acs.molpharmaceut.0c0057410.1021/acs.molpharmaceut.0c00574 ↗
56. 10.1016/j.addr.2017.10.00910.1016/j.addr.2017.10.009 ↗
57. 10.1016/S0895-3988(10)60024-410.1016/S0895-3988(10)60024-4 ↗
58. 10.1161/01.cir.0000437739.71477.ee10.1161/01.cir.0000437739.71477.ee ↗
59. 10.1038/s41598‐019‐43665‐x10.1038/s41598‐019‐43665‐x ↗
60. 10.1016/s0009‐8981(99)00072‐810.1016/s0009‐8981(99)00072‐8 ↗
61. 10.1016/j.jff.2015.11.03010.1016/j.jff.2015.11.030 ↗
62. 10.1039/c9fo03054a10.1039/c9fo03054a ↗
63. 10.1021/jf505584m10.1021/jf505584m ↗
64. 10.1016/j.lwt.2011.10.01110.1016/j.lwt.2011.10.011 ↗
65. 10.1039/c6fo01215a10.1039/c6fo01215a ↗
66. 10.1021/acs.jafc.5b0309910.1021/acs.jafc.5b03099 ↗
67. 10.1016/j.jchromb.2022.12357610.1016/j.jchromb.2022.123576 ↗
68. 10.1016/j.physbeh.2011.09.00410.1016/j.physbeh.2011.09.004 ↗
69. 10.1021/acs.analchem.0c0468610.1021/acs.analchem.0c04686 ↗
70. 10.1016/j.cmet.2023.07.01110.1016/j.cmet.2023.07.011 ↗
71. 10.1016/j.envint.2020.10588610.1016/j.envint.2020.105886 ↗
72. 10.1016/j.envint.2019.10543710.1016/j.envint.2019.105437 ↗
73. 10.1016/j.phymed.2023.15466010.1016/j.phymed.2023.154660 ↗
74. 10.1016/j.biopha.2021.11147910.1016/j.biopha.2021.111479 ↗
75. 10.3389/fimmu.2022.91693310.3389/fimmu.2022.916933 ↗
76. 10.1038/s41418‐024‐01393‐410.1038/s41418‐024‐01393‐4 ↗